Learnings from Implementation Strategies to Improve Lipid Management

Nick S R Lan1,2,3, Ruofei Trophy Chen4, Girish Dwivedi5,6,7

  • 1Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia. nick.lan@uwa.edu.au.

PubMed

Insights

Optimizing lipid management requires multifaceted strategies targeting clinicians and patients. Implementation science can guide future research on improving cardiovascular risk reduction through better low-density lipoprotein (LDL)-cholesterol control.

Area of Science:

  • Cardiovascular Medicine
  • Implementation Science
  • Health Services Research

Background:

  • Lowering low-density lipoprotein (LDL)-cholesterol is crucial for reducing cardiovascular risk.
  • Current guidelines recommend LDL-cholesterol goals, yet many high-risk patients do not achieve them or receive adequate therapy.
  • Real-world studies indicate a gap in achieving optimal lipid management and therapy intensity.

Purpose of the Study:

  • To review recent implementation strategies for optimizing lipid management in clinical practice.
  • To discuss approaches for improving patient attainment of LDL-cholesterol goals and therapy adherence.

Main Methods:

  • Review of contemporary real-world studies on lipid management implementation.
  • Analysis of clinician-level interventions, including team-based care and decision support.
  • Evaluation of patient-focused strategies for adherence and system-level approaches like EHRs and telehealth.

Main Results:

  • Multidisciplinary care, pharmacist/nurse-led interventions, and educational initiatives show promise at the clinician level.
  • Patient education, shared decision-making, and behavioral support improve adherence.
  • Electronic health records and telehealth models offer cost-effective ways to identify patients and improve access to care.

Conclusions:

  • Multifaceted strategies addressing clinician, patient, and system factors are effective for improving lipid management.
  • Future research should incorporate implementation science frameworks to assess long-term outcomes, sustainability, and scalability.
  • Understanding barriers and facilitators is key for broader application of successful strategies.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
529
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
366
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...